drugset / Trial / NCT02070692
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Phase 4
Completed
56 enrolled
Oregon Health and Science University
Society of Family Planning · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to study whether a drug called tamoxifen can reduce vaginal bleeding in women who are using the Etonogestrel contraceptive implant.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 10 mg | — |